Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

527

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
Postoperative ComplicationsCataract
Interventions
DRUG

Bromfenac

One drop in study eye every 12 hours for 14 days

DRUG

Placebo

One drop in study eye every 12 hours for 14 days

Trial Locations (39)

11570

Ophthalmic Consultants of Long Island, Rockville Centre

19104

Scheie Eye Institute, Philadelphia

23507

Virginia Eye Consultants, Norfolk

28211

Horizon Eye Care, Charlotte

30742

Advanced Eye Care, PC, Fort Oglethorpe

33321

Marvin E Greenberg, MD, PA, Tamarac

33401

Jack Daubert, MD, West Palm Beach

33431

Cohen Laser Vision Center, Boca Raton

33511

Brandon Cataract Center & Eye Clinic, Brandon

35205

Harold A Helms, MD, Birmingham

38501

Middle Tennessee Eye Associates, Cookeville

41017

Cincinnati Eye Institute NKY, Edgewood

49085

Great Lakes Eye Care, Saint Joseph

57701

Black Hills Regional Eye Institute, Rapid City

64111

Hunkeler Eye Institute, Kansas City

67530

Donald E Beahm, MD, Great Bend

70112

Tulane University Health Sciences Center, New Orleans

70119

Stevenson Medical Surgical Eye Center, New Orleans

72205

Eye Care Arkansas, PA, Little Rock

73104

Dean A McGee Eye Institute, Oklahoma City

74104

The Eye Institute, Tulsa

77025

Houston Eye Associates, Houston

77555

Ophthalmology Visual Science, Galveston

78209

David G Shulman, MD, San Antonio

78234

Ophthalmology Service, Brooke Army Medical Center, Fort Sam Houston

78666

Central Texas Eye Center, San Marcos

78705

Texan Eye Care PA, Austin

80120

E Randy Craven, MD, Littleton

83686

Saltzer Medical Group, PA, Nampa

87102

Arthur J Weinstein, MD, Albuquerque

92103

Eye Care of San Diego, San Diego

92663

Anesthetic Eye Care Institute, Newport Beach

92697

UCI, Department of Ophthalmology, Irvine

95128

Santa Clara Valley Medical Center, San Jose

95819

Richard A Lewis, MD, Sacramento

97201

Casey Eye Institute, Portland

97209

Eye Health Northwest, Portland

06510

The Eye Care Group, New Haven

02114

Cornea Consultants, Boston

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00198445 - Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery | Biotech Hunter | Biotech Hunter